Immune cells play a key role in mediating inflammatory responses. Dysregulation in signaling mechanisms that operate across immune cells can trigger chronic inflammatory diseases like rheumatoid arthritis that cause pain ...
Nov 24, 2021
0
12
Ground-breaking research from Heriot-Watt University and the University of Texas Medical Branch is set to be commercialized following a funding award from Scottish Enterprise's High Growth Spinout Programme.
Nov 12, 2021
0
21
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that people with chronic inflammatory diseases, such as rheumatoid arthritis (RA), who take immunosuppressive ...
Nov 2, 2021
0
47
Chronic inflammatory bowel disease (IBD) are inflammations of the gastrointestinal tract which flare up in phases and are accompanied by bloody bowel movements, diarrhea and severe impairment of the quality of life. IBD patients ...
Nov 1, 2021
0
17
An analysis of published studies has found a link between the use of antihypertensive mediations and the development of psoriasis, a chronic inflammatory skin disease.
Oct 6, 2021
0
23
Chronic inflammation in the gut, internationally known as Inflammatory Bowel Disease (IBD), is a growing problem in the world, especially in developing countries. The Netherlands already has about 90,000 IBD patients. At ...
Sep 27, 2021
0
5
UCL researchers have shown that damage to the lining of the gut plays an important role in the development of rheumatoid arthritis, paving the way for a new approach to treating the disease.
Sep 6, 2021
0
339
COVID-19 vaccination elicited antibody responses in nearly nine out of 10 people with weakened immune systems, although their responses were only about one-third as strong as those mounted by healthy people, according to ...
Aug 31, 2021
0
246
Hidradenitis suppurativa (Syn. Acneinversa) is one of the most troublesome and complicated skin diseases. The anti-inflammatory drug adalimumab can improve symptoms; however, patients also often have to undergo surgery. Until ...
Aug 19, 2021
0
2
Johns Hopkins Medicine researchers have identified a protein—DMBT1S8—as a target for potential therapies to treat inflammation in the nasal and sinus cavities.
Jun 10, 2021
0
4
